These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 27639537)

  • 1. Clinical relevance of the bile acid receptor TGR5 in metabolism.
    van Nierop FS; Scheltema MJ; Eggink HM; Pols TW; Sonne DP; Knop FK; Soeters MR
    Lancet Diabetes Endocrinol; 2017 Mar; 5(3):224-233. PubMed ID: 27639537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGR5 in inflammation and cardiovascular disease.
    Pols TW
    Biochem Soc Trans; 2014 Apr; 42(2):244-9. PubMed ID: 24646225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion.
    Sonne DP; Hansen M; Knop FK
    Eur J Endocrinol; 2014 Aug; 171(2):R47-65. PubMed ID: 24760535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease.
    Chávez-Talavera O; Tailleux A; Lefebvre P; Staels B
    Gastroenterology; 2017 May; 152(7):1679-1694.e3. PubMed ID: 28214524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile-induced secretion of glucagon-like peptide-1: pathophysiological implications in type 2 diabetes?
    Knop FK
    Am J Physiol Endocrinol Metab; 2010 Jul; 299(1):E10-3. PubMed ID: 20424139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice.
    McGavigan AK; Garibay D; Henseler ZM; Chen J; Bettaieb A; Haj FG; Ley RE; Chouinard ML; Cummings BP
    Gut; 2017 Feb; 66(2):226-234. PubMed ID: 26511794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disorders.
    Stepanov V; Stankov K; Mikov M
    J Recept Signal Transduct Res; 2013 Aug; 33(4):213-23. PubMed ID: 23782454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gluco-Metabolic Effects of Pharmacotherapy-Induced Modulation of Bile Acid Physiology.
    Brønden A; Knop FK
    J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31630179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between bile acid concentration, glucagon-like-peptide 1, fibroblast growth factor 15 and bile acid receptors in rats during progression of glucose intolerance.
    Yan X; Li P; Tang Z; Feng B
    BMC Endocr Disord; 2017 Sep; 17(1):60. PubMed ID: 28946907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1.
    Katsuma S; Hirasawa A; Tsujimoto G
    Biochem Biophys Res Commun; 2005 Apr; 329(1):386-90. PubMed ID: 15721318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation.
    Chiang JY; Pathak P; Liu H; Donepudi A; Ferrell J; Boehme S
    Dig Dis; 2017; 35(3):241-245. PubMed ID: 28249273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal bile acid receptors are key regulators of glucose homeostasis.
    Trabelsi MS; Lestavel S; Staels B; Collet X
    Proc Nutr Soc; 2017 Aug; 76(3):192-202. PubMed ID: 27846919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red ginseng extracts ameliorate high-fat diet-induced obesity and insulin resistance by activating the intestinal TGR5-mediated bile acids signaling pathway.
    Li W; Zhuang T; Wang Z; Wang X; Liu L; Luo Y; Wang R; Li L; Huang W; Wang Z; Yang L; Ding L
    Phytomedicine; 2023 Oct; 119():154982. PubMed ID: 37531904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGR5-mediated bile acid sensing controls glucose homeostasis.
    Thomas C; Gioiello A; Noriega L; Strehle A; Oury J; Rizzo G; Macchiarulo A; Yamamoto H; Mataki C; Pruzanski M; Pellicciari R; Auwerx J; Schoonjans K
    Cell Metab; 2009 Sep; 10(3):167-77. PubMed ID: 19723493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGR5 agonists for diabetes treatment: a patent review and clinical advancements (2012-present).
    Bhimanwar RS; Mittal A
    Expert Opin Ther Pat; 2022 Feb; 32(2):191-209. PubMed ID: 34652989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acids and the membrane bile acid receptor TGR5--connecting nutrition and metabolism.
    Thomas C; Auwerx J; Schoonjans K
    Thyroid; 2008 Feb; 18(2):167-74. PubMed ID: 18279017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginsenoside Ro Ameliorates High-Fat Diet-Induced Obesity and Insulin Resistance in Mice via Activation of the G Protein-Coupled Bile Acid Receptor 5 Pathway.
    Jiang LS; Li W; Zhuang TX; Yu JJ; Sun S; Ju ZC; Wang ZT; Ding LL; Yang L
    J Pharmacol Exp Ther; 2021 Jun; 377(3):441-451. PubMed ID: 33820830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential New Approaches to Modifying Intestinal GLP-1 Secretion in Patients with Type 2 Diabetes Mellitus : Focus on Bile Acid Sequestrants.
    Holst JJ; McGill MA
    Clin Drug Investig; 2012 Jan; 32(1):1-14. PubMed ID: 27933595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGR5: a novel target for weight maintenance and glucose metabolism.
    Chen X; Lou G; Meng Z; Huang W
    Exp Diabetes Res; 2011; 2011():853501. PubMed ID: 21754919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Bile Acids in Glucose Metabolism and Their Relation with Diabetes.
    González-Regueiro JA; Moreno-Castañeda L; Uribe M; Chávez-Tapia NC
    Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):16-21. PubMed ID: 29118282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.